Stimulants: epidemiology and impact on mental health

by Professor Fabrizio Schifano and Dr Antonio Albanese

 

Last updated: February 2019

 

In the second half of the 1990s, a global trend of escalating stimulant misuse (such as cocaine, amphetamine, methamphetamine, methylenedioxymethamphetamine/ MDMA and MDMA-like drugs, cathinone derivatives, and benzylpiperazine/BZP) was observed across a number of EU countries.

 

When reorganising statutory and non-statutory services to cope with this increasingly widespread clinical issue, the epidemiological approach is of paramount importance, and a clear appreciation of the levels of stimulant misuse is necessary in order to allocate the appropriate levels of resources.

 

Stimulant misuse is typically associated with an imbalance of neurotransmitters, especially dopamine. Therefore, practising psychiatrists need to be aware of the psychopathological consequences related to substance misuse in order to refine their own diagnostic and clinical management skills.

 

Start the module

 

 

If you like this module, you may also be interested in:

 

Stimulants: treatment approaches and organising services by Prof Fabrizio Schifano and Dr Antonio Albanese

 

Alcohol-related brain damage by Prof Kenneth Wilson, Dr Joy Bell and Dr Vanessa Craig

 

Buprenorphine in opioid dependence by Dr Lucinda M. Cockayne and Ms Elizabeth Hutchings

 

Helping the addicted doctor by Dr Elizabeth Hare and Dr Malcolm Bruce

 

Drug Misuse: Psychosocial Interventions - The NICE Guideline (book from RCPsych publications)

 

 

BJPsych Advances: related articles for CPD Online

 

 

Related Advances articles

 

Download take-home notes to print and annotateDownload take-home notes to print and annotate

 

© 2019 Royal College of Psychiatrists